Dronedarone approved

Links shared publicly online about this topic.

  • 1,927
    total visits

Dronedarone approved

theheart.org

Dronedarone is envisioned as a safer alternative to amiodarone, a widely used antiarrhythmic agent in patients with AF.

View full resource at theheart.org

Tags: Heart Disease, Arrhythmia, Atrial Fibrillation, FDA, Antiarrhythmic Medication, Multaq, Cordarone

  • Share

Most Recently Shared on July 2, 2009 at 4:35 pm By:

theheartorg Shelley Wood

heartwire: FDA approves dronedarone for atrial fibrillation http://bit.ly/4eV82V

3 years ago...

Lawmakers seek faster approval process for shortage drugs - amednews.com

ama-assn.org — “A House subcommittee adds legislative language on shortages to the user-fee reauthorization bill.View full resource at ama-assn.org

  • View Related
  • Share

Most Recently Shared on April 30, 2012 at 8:20 pm By:

amednews AmericanMedicalNews Health Organization and Health News

An expedited review track is being considered as possible solution to national shortages of certain drugs http://t.co/dS8HIkig

6 days ago...

A New Drug Used by 71-Year-Old Marathoner Don Wright Could Soon Be Approved to Help More Patients with Multiple Myeloma Says Tackle Cancer Foundation - MarketWatch

marketwatch.com — “A New Drug Used by 71-Year-Old Marathoner Don Wright Could Soon Be Approved to Help More Patients with Multiple Myeloma Says Tackle Cancer Foundation - MarketWatchView full resource at marketwatch.com

  • View Related
  • Share

Most Recently Shared on April 30, 2012 at 12:42 pm By:

Drugs_Devices Drugs and Devices OW OW Health

A New Drug Used by 71-Year-Old Marathoner Don Wright Could Soon Be Approved to ... - MarketWatch (press re... http://t.co/Btfg7vsq #drug

6 days ago...

No Easy Cure for Diabetic Children - WSJ.com

online.wsj.com — “The only pill approved in the U.S. for treatment of children with type 2 diabetes is proving surprisingly ineffective, heightening worries about the fast-growing and largely preventable disease.View full resource at online.wsj.com

  • View Related
  • Share

Most Recently Shared on April 29, 2012 at 10:31 pm By:

diabetesmyths Riva Greenberg Patient Expert

Only half of kids with type 2 seem able to control their blood sugar despite good compliance, http://t.co/zxuiJqWn

7 days ago...

FDA Approves New Erectile Dysfunction Drug Stendra

webmd.com — “The FDA has approved Stendra (avanafil) for men with erectile dysfunction (ED).View full resource at webmd.com

  • View Related
  • Share

Most Recently Shared on April 27, 2012 at 7:18 pm By:

knoxvillehosp Knoxville Hospital Hospital

FDA Approves New Erectile Dysfunction Drug Stendra: The FDA has approved Stendra (avanafil) for men with erectil... http://t.co/cPg8sc7r

1 week ago...

FDA approves Stendra for erectile dysfunction

fda.gov — “The U.S. Food and Drug Administration today approved Stendra (avanafil), a new drug to treat erectile dysfunction.View full resource at fda.gov

  • View Related
  • Share

Most Recently Shared on April 27, 2012 at 6:59 pm By:

eyeonfda eyeonfda Health Lawyer and Pharma

#FDA issues press release about approval of Vivus ED drug Stendra - http://t.co/deRucBA2

1 week ago...

House passes student loan bill, health fund cuts - POLITICO.com

politico.com — “The House on Friday approved a bill that would prevent a large increase in student loan interest rates, but only by wiping out a preventive health care fund in the health reform law — a nonstarter with President Barack Obama and congressional Democrats. The bill now moves to the Senate, where Majority Leader Harry Reid said Democrats would block...View full resource at politico.com

  • View Related
  • Share

Most Recently Shared on April 27, 2012 at 5:34 pm By:

AHLAlerts American Health Line Health News

House passes student loan bill, would eliminate #HCR's prevention & public health fund http://t.co/sMef6FoF (via @politico)

1 week ago...

Ironwood faces 3-month FDA delay for potential IBS drug linaclotide - Boston Business Journal

bizjournals.com — “Ironwood Pharmaceuticals Inc. (Nasdaq: IRWD) and its partner Forest Laboratories Inc. (NYSE: FRX) have announced the U.S. Food and Drug Administration will delay its approval decision for the companies’ potential drug for irritable bowel syndrome (IBS), called linaclotide.View full resource at bizjournals.com

  • View Related
  • Share

Most Recently Shared on April 24, 2012 at 7:18 pm By:

IBD_Wisdom Inflammatory Bowel Syndrome OW Health

Ironwood faces 3-month FDA delay for potential IBS drug linaclotide: Ironwood Pharmaceuticals Inc. (Nasdaq: IRWD... http://t.co/l5H6RRmq

2 weeks ago...

No frown lines as onabotulinumtoxinA turns 10 - - ModernMedicine

modernmedicine.com — “April 15 marked the 10-year anniversary of FDA approval of onabotulinumtoxinA (Botox Cosmetic, Allergan) to help improve the look of moderate to severe frown lines between the eyebrows in patients aged 18 to 65 years.View full resource at modernmedicine.com

  • View Related
  • Share

Most Recently Shared on April 24, 2012 at 5:51 pm By:

Alimera eye drug inches closer to launch with Austria approval | Reuters

reuters.com — “(Reuters) - Biopharmaceutical company Alimera Sciences Inc said the Austrian health regulator approved its experimental drug for retinal swelling, raising hopes for the company's most advanced treatment,View full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on April 24, 2012 at 3:33 pm By:

HealthPassion HealthPassion Health News

Alimera eye drug inches closer to launch with Austria approval: (Reuters) - Biopharmaceutical company Alimera Sc... http://t.co/wsfmVFRt

2 weeks ago...

It's been 10 years... | Facebook

facebook.com — “Center for Aesthetics and Plastic Surgery wrote: It's been 10 years since Botox was... Join Facebook to connect with Center for Aesthetics and Plastic Surgery and others you may know.View full resource at facebook.com

  • View Related
  • Share

Most Recently Shared on April 24, 2012 at 1:27 pm By:

sringlermd Steven Ringler, MD Active Health Library, Doctor, Surgeon, Plastic Surgeon, and Physician

It's been 10 years since Botox was approved by the FDA for reducing wrinkles. Since then, 5.6 million women and... http://t.co/E6JP6WPM

2 weeks ago...

Alzheimer's Advisory Council Approves Its Recommendations for First National Alzheimer's Plan

prnewswire.com — “Alzheimer's Advisory Council Approves Its Recommendations for First National Alzheimer's Plan.View full resource at prnewswire.com

  • View Related
  • Share

Most Recently Shared on April 24, 2012 at 1:02 pm By:

JGNJournal JGNJournal Nursing and Medical Journal

@alzassociation: #Alzheimer's Advisory Council Approves Recommendations for 1st Nat'l Alzheimer's Plan http://t.co/xnQIS5Ea

2 weeks ago...

TGA approves Ikaria’s LUCASSIN to treat Hepatorenal Syndrome Type 1

news-medical.net — “Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies for critically ill patients, announced today the approval of LUCASSIN (terlipressin) by the Therapeutic Goods Administration (TGA) of Australia.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on April 24, 2012 at 4:33 am By:

NewsMedical News-Medical.Net Health News

TGA approves Ikaria’s LUCASSIN to treat Hepatorenal Syndrome Type 1: Ikaria, Inc., a critical care company focus... http://t.co/kZbCI8di

2 weeks ago...

No frown lines as onabotulinumtoxinA turns 10 - - ModernMedicine

modernmedicine.com — “April 15 marked the 10-year anniversary of FDA approval of onabotulinumtoxinA (Botox Cosmetic, Allergan) to help improve the look of moderate to severe frown lines between the eyebrows in patients aged 18 to 65 years.View full resource at modernmedicine.com

  • View Related
  • Share

Most Recently Shared on April 23, 2012 at 11:48 pm By:

Bariatric surgery maintains, doesn't gain - amednews.com

ama-assn.org — “Once a fast-growing procedure, its numbers have plateaued because of the deep recession and other societal forces.View full resource at ama-assn.org

  • View Related
  • Share

Most Recently Shared on April 23, 2012 at 9:19 pm By:

amednews AmericanMedicalNews Health Organization and Health News

25% of patients considering bariatric surgery are denied coverage 3 times before approval http://t.co/ClGiYMHZ

2 weeks ago...

FDA approves i-Lipo fat-reduction device - - ModernMedicine

modernmedicine.com — “The Food and Drug Administration has cleared the i-Lipo (Chromogenex), a low-level laser diode fat-reduction device for body contouring, for U.S. marketing.View full resource at modernmedicine.com

  • View Related
  • Share

Most Recently Shared on April 23, 2012 at 5:45 am By:

Advertisement